HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel J Lovell Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2022Tofacitinib for juvenile idiopathic arthritis - Authors' reply.
1/2022Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
1/20222021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
1/20222021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
11/2021Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
10/2021Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
1/2021Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
1/2021Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
1/2021Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
12/2020Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel J Lovell Research Topics

Disease

60Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2022 - 07/2002
9Infections
11/2021 - 01/2003
7Arthritis (Polyarthritis)
11/2021 - 07/2002
5Rheumatic Diseases (Rheumatism)
12/2020 - 01/2008
5Dermatomyositis (Dermatopolymyositis)
11/2010 - 05/2005
4Pain (Aches)
06/2021 - 03/2009
4Fever (Fevers)
12/2020 - 12/2012
4Inflammation (Inflammations)
02/2017 - 11/2004
3Rheumatoid Arthritis
10/2021 - 01/2016
3Body Weight (Weight, Body)
01/2021 - 12/2012
3Glomerulonephritis
06/2020 - 11/2009
3Familial Mediterranean Fever (Periodic Disease)
07/2014 - 10/2012
3Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2012 - 11/2009
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
10/2012 - 11/2009
3Vasculitis (Vasculitides)
10/2012 - 11/2009
2Uveitis
06/2020 - 11/2019
2Injection Site Reaction
01/2018 - 10/2012
2Tuberculosis (Tuberculoses)
10/2013 - 10/2013
2Churg-Strauss Syndrome (Allergic Angiitis)
08/2012 - 11/2009
2Microscopic Polyangiitis
08/2012 - 11/2009
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2005 - 05/2005
2Cryopyrin-Associated Periodic Syndromes
04/2005 - 12/2002
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Negative rheumatoid factor polyarthritis
11/2021
1Psoriatic Arthritis
12/2020
1Sjogren's Syndrome (Sjogren Syndrome)
06/2020
1Autoimmune Diseases (Autoimmune Disease)
06/2020
1Diphtheria
02/2020
1Tetanus
02/2020
1Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1Glaucoma
11/2019
1Spondylitis
01/2019
1Stomach Ulcer (Gastric Ulcer)
06/2018
1Chronic Disease (Chronic Diseases)
04/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2015
1Rare Diseases (Rare Disease)
07/2014
1Exanthema (Rash)
09/2013
1Macrophage Activation Syndrome
12/2012
1Tinea Capitis
07/2012
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2012

Drug/Important Bio-Agent (IBA)

11Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 07/2002
8Biological ProductsIBA
01/2022 - 03/2009
8Abatacept (Orencia)FDA Link
01/2021 - 08/2008
6Antirheumatic Agents (DMARD)IBA
01/2022 - 08/2008
6Rheumatoid FactorIBA
11/2021 - 06/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 08/2008
6Etanercept (Enbrel)FDA Link
10/2012 - 01/2003
5Infliximab (Remicade)FDA Link
11/2019 - 09/2007
4canakinumabFDA Link
12/2020 - 12/2012
4C-Reactive ProteinIBA
10/2020 - 12/2012
4Adalimumab (Humira)FDA Link
10/2020 - 08/2008
4Adrenal Cortex Hormones (Corticosteroids)IBA
02/2020 - 07/2006
4rilonaceptFDA Link
07/2014 - 10/2012
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2012 - 11/2009
3tofacitinibIBA
01/2022 - 12/2017
3GlucocorticoidsIBA
01/2021 - 12/2012
3CytokinesIBA
06/2020 - 12/2002
3S100A12 ProteinIBA
01/2020 - 05/2005
3Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2013
3Naproxen (Naprosyn)FDA LinkGeneric
06/2018 - 05/2006
3Interleukin-1 (Interleukin 1)IBA
12/2012 - 12/2002
2golimumabFDA Link
10/2021 - 01/2018
2tocilizumab (atlizumab)FDA Link
01/2021 - 01/2021
2Pharmaceutical PreparationsIBA
07/2018 - 04/2015
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2018 - 01/2014
2AutoantibodiesIBA
01/2018 - 05/2005
2Prostaglandins AIBA
01/2018 - 05/2012
2Celecoxib (Celebrex)FDA Link
01/2014 - 01/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2012 - 05/2005
2SteroidsIBA
07/2012 - 07/2002
2Biomarkers (Surrogate Marker)IBA
12/2008 - 04/2005
2CalciumIBA
12/2008 - 07/2006
1secukinumabIBA
01/2022
1Certolizumab PegolFDA Link
01/2022
1ixekizumabIBA
01/2022
1N-phthaloylglutamic acidIBA
06/2021
1ametantrone (HAQ)IBA
01/2021
1ORALIT (ORS)IBA
06/2020
1Diphtheria-Tetanus VaccineIBA
02/2020
1VaccinesIBA
02/2020
1S100 Proteins (S 100 Protein)IBA
01/2020
1Antinuclear AntibodiesIBA
01/2019
1Proton Pump InhibitorsIBA
06/2018
1Esomeprazole (Nexium)FDA Link
06/2018
1AutoantigensIBA
01/2018
1Oncogene Proteins (Oncogene Protein)IBA
01/2018
1TabletsIBA
12/2017
1SolutionsIBA
12/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2017
1AntigensIBA
02/2017
1SDMIBA
04/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1ColchicineFDA LinkGeneric
10/2012
1Griseofulvin (Grifulvin V)FDA LinkGeneric
07/2012
1Tumor Necrosis Factor InhibitorsIBA
06/2010

Therapy/Procedure

22Therapeutics
01/2022 - 07/2002
2Drug Therapy (Chemotherapy)
01/2022 - 07/2002
1Drug Tapering
12/2020
1Injections
01/2018